Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cilag GMBH International

Division of Johnson & Johnson
www.cilag.ch

Latest From NanoViricides Inc.

Pilgrimage And Pipeline: MERS Prospects

The renewed break-out of a frighteningly deadly virus with no known cure or vaccine in a region that will shortly host a couple of million international pilgrims has prompted a rash of recent headlines linking Middle East Respiratory Syndrome (MERS), the SARS-like coronavirus that first emerged in Saudi Arabia in 2012, and the annual Hajj to Mecca.

Infectious Diseases Neurology

AbbVie/United Therapeutics $350m Voucher Deal: Smart Move?

AbbVie became the latest firm to test the FDA "voucher" strategy as a pathway to success – entering into a $350m deal with United Therapeutics in an effort to get an experimental medicine to the market quicker.

Metabolic Disorders Infectious Diseases

Ebola – the industry's response in antivirals

The unprecedented scale of the Ebola epidemic in West Africa has prompted a similarly unprecedented interest in the response from the pharma and biotech industries to develop treatments and vaccines against the virus.

Cardiovascular Infectious Diseases

Deals Shaping The Medical Industry, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cilag AG
  • Cilag AG International
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Johnson & Johnson
  • Senior Management
  • Contact Info
  • Cilag GMBH International
    Phone: (41) 41 725 5050
    Gubelstrasse 34
    Zug, 6300
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register